Ahman H - Search Results

1

Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid.

Korkeila M, Lehtonen H, Ahman H, Leroy O, Eskola J, Käyhty H. Korkeila M, et al. Among authors: ahman h. Vaccine. 2000 Jan 18;18(13):1218-26. doi: 10.1016/s0264-410x(99)00393-x. Vaccine. 2000. PMID: 10649623 Clinical Trial.

2

Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children.

Käyhty H, Ahman H, Rönnberg PR, Tillikainen R, Eskola J. Käyhty H, et al. Among authors: ahman h. J Infect Dis. 1995 Nov;172(5):1273-8. doi: 10.1093/infdis/172.5.1273. J Infect Dis. 1995. PMID: 7594664 Clinical Trial.

3

Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants.

Ahman H, Käyhty H, Tamminen P, Vuorela A, Malinoski F, Eskola J. Ahman H, et al. Pediatr Infect Dis J. 1996 Feb;15(2):134-9. doi: 10.1097/00006454-199602000-00009. Pediatr Infect Dis J. 1996. PMID: 8822286

4

Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory.

Ahman H, Käyhty H, Lehtonen H, Leroy O, Froeschle J, Eskola J. Ahman H, et al. Pediatr Infect Dis J. 1998 Mar;17(3):211-6. doi: 10.1097/00006454-199803000-00008. Pediatr Infect Dis J. 1998. PMID: 9535248 Clinical Trial.

5

Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.

Anttila M, Eskola J, Ahman H, Käyhty H. Anttila M, et al. Among authors: ahman h. J Infect Dis. 1998 Jun;177(6):1614-21. doi: 10.1086/515298. J Infect Dis. 1998. PMID: 9607841

6

Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood.

Anttila M, Eskola J, Ahman H, Käyhty H. Anttila M, et al. Among authors: ahman h. Vaccine. 1999 Apr 9;17(15-16):1970-7. doi: 10.1016/s0264-410x(98)00458-7. Vaccine. 1999. PMID: 10217596 Clinical Trial.

7

Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid.

Ahman H, Käyhty H, Vuorela A, Leroy O, Eskola J. Ahman H, et al. Vaccine. 1999 Jun 4;17(20-21):2726-32. doi: 10.1016/s0264-410x(99)00048-1. Vaccine. 1999. PMID: 10418924 Clinical Trial.

8

Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine.

Nurkka A, Ahman H, Korkeila M, Jäntti V, Käyhty H, Eskola J. Nurkka A, et al. Among authors: ahman h. Pediatr Infect Dis J. 2001 Jan;20(1):25-33. doi: 10.1097/00006454-200101000-00006. Pediatr Infect Dis J. 2001. PMID: 11176563

9

Tolerability and immunogenicity of an eleven-valent pneumococcal conjugate vaccine in healthy toddlers.

Wuorimaa T, Dagan R, Eskola J, Janco J, Ahman H, Leroy O, Käyhty H. Wuorimaa T, et al. Among authors: ahman h. Pediatr Infect Dis J. 2001 Mar;20(3):272-7. doi: 10.1097/00006454-200103000-00011. Pediatr Infect Dis J. 2001. PMID: 11303829

10

Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT.

Nurkka A, Ahman H, Yaich M, Eskola J, Käyhty H. Nurkka A, et al. Among authors: ahman h. Vaccine. 2001 Oct 12;20(1-2):194-201. doi: 10.1016/s0264-410x(01)00250-x. Vaccine. 2001. PMID: 11567764 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters